**Core Concept**
The refinement of serum PSA levels is crucial in the early detection and diagnosis of prostate cancer. Total PSA (tPSA) measures the total amount of PSA in the blood, while free PSA (fPSA) measures the amount of PSA not bound to proteins. The ratio of free to total PSA (fPSA/tPSA) has been used to differentiate between benign and malignant conditions of the prostate.

**Why the Correct Answer is Right**
The correct answer is % Free PSA (%fPSA). The %fPSA is used to determine the need for a TRUS-guided biopsy of the prostate, even when the level of serum PSA is still within the normal range. This is because a lower %fPSA (< 10-12%) is associated with a higher likelihood of prostate cancer, whereas a higher %fPSA (≥ 25%) is associated with benign prostatic hyperplasia (BPH) or prostatitis. The use of %fPSA helps to refine the risk assessment and guide the decision for biopsy. **Why Each Wrong Option is Incorrect** **Option A:** Prostate-Specific Antigen Density (PSAD) is calculated by dividing the PSA level by the volume of the prostate, and while it can be useful in men with a large prostate, it is not the refinement of serum PSA used to determine the need for biopsy in men with normal PSA levels. **Option B:** Age-adjusted PSA levels take into account the natural increase in PSA levels with age, but they do not provide a clear indication for biopsy in men with normal PSA levels. **Option C:** Digital Rectal Examination (DRE) is a physical examination used to assess the prostate, but it is not a refinement of serum PSA levels and is not used to determine the need for biopsy. **Clinical Pearl / High-Yield Fact** A lower %fPSA (< 10-12%) should prompt further investigation, including a TRUS-guided biopsy, even in men with normal PSA levels. **Correct Answer:** B. % Free PSA (%fPSA).